60.7
ARS Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
278
FY23:
232
FY24:
334
FY25:
285
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.72
FY22:
3.74
FY23:
1.46
FY24:
16.9
FY25:
42.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
61.4
FY22:
281
FY23:
233
FY24:
351
FY25:
328
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.19
FY22:
5.44
FY23:
2.39
FY24:
23.4
FY25:
39.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.49
FY22:
3.11
FY23:
0.04
FY24:
70.9
FY25:
174
(positive)
Change from FY21 to FY25
millions USD
FY21:
−31.3
FY22:
273
FY23:
231
FY24:
257
FY25:
114
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
281
FY23:
233
FY24:
351
FY25:
328
All amounts in millions USD